Aronex Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Ahmedabad India (2004)
Status: Acquired by Agenus Inc. (2001)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (3)

amphotericin b (fungizone) (1 trial)

deoxycholic acid (kybella) (1 trial)

nystatin (mycostatin) (1 trial)

Drugs in Phase 2 Trials (2)

aroplatin (4 trials)

capecitabine (xeloda) (1 trial)

Drugs in Phase 1 Trials (1)

zintevir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Colorectal Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

HIV Infections (Phase 1)

Lymphoma (Phase 3)

Multiple Myeloma (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Plasmacytoma (Phase 3)

Preleukemia (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 6